通过在诱导多能干干细胞中进行主要编辑来丰富基编辑结果
Ryo Niwa1,2, Tomoko Matsumoto1, Alexander Y Liu1
1Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
The CRISPR journal
|October 22, 2024
概括
与标准的Cas9方法相比,主要编辑 (PE) 在人类干细胞基因编辑中提供了更高的精度. 这项研究证明了PE PE.
科学领域:
- 干细胞生物学 干细胞生物学
- 基因编辑技术 基因编辑技术
- 分子遗传学 分子遗传学
背景情况:
- 人类诱导多能干细胞 (iPS) 中的基因编辑对于疾病建模至关重要.
- 传统的双链断裂修复方法可能会导致不必要的目标突变.
- 主编辑 (PE) 通过结合Cas9尼克酶和逆转录酶提供了更精确的替代方案.
研究的目的:
- 在人类iPS细胞中实施GMP兼容的原始编辑协议.
- 为了比较原始编辑与标准Cas9基因编辑的精度和结果.
- 研究主要编辑表达水平对编辑效率和等位基结果的影响.
主要方法:
- 开发了一个符合GMP的协议,用于将Cas9或PE-2A-mCherry等离子体转化为人类iPS细胞.
- 在HEK3和APOE位置使用GFP-to-BFP转换试验进行编辑评估.
- 基于PE表达水平的分离细胞,使用光激活细胞分类.
主要成果:
- 主编辑表现出比Cas9方法更高的精度,特别是在高表达水平.
- 基于PE表达的细胞分类影响了基编辑结果在目标位置.
- 通过使用PE,APOE阿尔茨海默氏症风险位和HEK3基准位成功编辑高精度.
结论:
- 主编辑为生成基因编辑的人类iPS细胞提供了更高的精度.
- 控制PE表达水平对于实现所需的等位基编辑结果至关重要.
- 这项工作促进了用于研究的具有特定异合体和同合体基因型的iPS细胞的产生.
更多相关视频
相关概念视频
Chromatin Modification in iPS Cells
1.6K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.6K
Induced Pluripotent Stem Cells
21.8K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
21.8K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K


